NBY - NovaBay Pharmaceuticals Inc.

NBY Stock Chart

NBY Profile

NovaBay Pharmaceuticals, Inc., a pharmaceutical firm based in Emeryville, California, specializes in the development and global distribution of eyecare and skincare solutions. Established in 2000, the company focuses on enhancing ocular health with its flagship product, Avenova. Avenova is designed to effectively remove microorganisms and debris from the skin surrounding the eye, particularly the eyelid, addressing various eye-related conditions.

In addition to its eyecare portfolio, NovaBay Pharmaceuticals also offers innovative wound care products marketed under the NeutroPhase and PhaseOne brands. These products cater to medical professionals and patients seeking advanced solutions for wound management and infection control.

Expanding its scope beyond medical treatments, NovaBay Pharmaceuticals addresses diverse skincare needs through its DERMAdoctor brand. This includes solutions for dermatological concerns such as keratosis pilaris, rosacea, eczema, anti-aging treatments, sun protection (SPF), hyperhidrosis, excessive hair, and acne. The company distributes its products through various retail channels, digital beauty platforms, distributors, and online channels, ensuring broad accessibility to its innovative skincare solutions.

Formerly known as NovaCal Pharmaceuticals, Inc., the company rebranded as NovaBay Pharmaceuticals, Inc. in February 2007, marking a strategic shift towards expanding its product offerings and market presence in the pharmaceutical industry. With a commitment to research and development, NovaBay Pharmaceuticals continues to drive innovation in healthcare solutions aimed at improving patient outcomes globally.

NBY Revenue Chart

NBY Earnings

Analyst Ratings